120 Participants Needed

Diagnostic Monitoring Techniques for Light Sensitivity

JF
JN
Overseen ByJulie Nellis, BSN
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial seeks new ways to diagnose and monitor light sensitivity and headaches by examining how eyes and nerves react to light. It employs various techniques, such as special eye scans and sensors, to measure these reactions. Methods include Electrophysiology (with tests like Electroretinography and Visual Evoked Potentials), Ocular Coherence Tomography (OCT), Pupillography, Videography, and a wrist-watch sensor device. The trial involves different groups: individuals with traumatic brain injuries (TBI) with and without light sensitivity, migraine sufferers with and without light sensitivity, and healthy individuals. Those with photosensitivity from other causes or a history of TBI may be suitable candidates. Participants should not have eye disorders or conditions that could affect eye or nerve responses. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve diagnosis and monitoring methods for light sensitivity and headaches.

Will I have to stop taking my current medications?

You may need to stop taking certain medications, especially those that affect pupil size or are sedatives, like benzodiazepines or opioids, as they could interfere with the study measurements.

What prior data suggests that these diagnostic monitoring techniques are safe for light sensitivity?

Research shows that the diagnostic tools tested in this trial, including electrophysiology, OCT, pupillography, videography, and wrist-watch sensors, are generally safe for people.

Electrophysiology measures the eye's electrical activity. Studies have found it to be widely used and safe in both research and medical settings.

Ocular Coherence Tomography (OCT) scans the eye to take detailed pictures without invasive procedures. It is considered safe and is often used to diagnose eye conditions.

Pupillography measures the pupil's response to light. This well-known method requires little effort from the patient and is commonly used without reports of harm.

Videography and wrist-watch sensors are non-contact methods. Videography captures facial features, while wrist-watch sensors monitor light exposure and other data. Both are safe and do not involve risky procedures.

Overall, previous patients have well-tolerated these tools. They are non-invasive, meaning they do not involve surgery or entering the body, which generally means fewer risks.12345

Why are researchers excited about this trial?

Researchers are excited about these diagnostic techniques for light sensitivity because they offer innovative ways to monitor and understand this condition. Unlike traditional methods that might only assess symptoms through patient self-reporting, these techniques use advanced tools like electrophysiology, which measures electrical activity in the eye, and Ocular Coherence Tomography (OCT), providing detailed images of the eye's internal structures. Pupillography and videography offer dynamic insights into how the pupils respond to light, while the wrist-watch sensor device allows for continuous, non-invasive monitoring of light exposure and sensitivity. Together, these methods could provide a more comprehensive understanding of light sensitivity, potentially leading to better-targeted treatments in the future.

What evidence suggests that these diagnostic monitoring techniques are effective for light sensitivity?

This trial will compare various diagnostic methods to understand light sensitivity and headaches across different participant groups. Research has shown that each method provides unique insights into these conditions. Electrophysiology, one method being tested, measures electrical signals in the eye and brain, with a 75% success rate in identifying visual problems and an 87.5% accuracy in ruling them out. OCT, another method in this trial, safely images eye health and accurately diagnoses eye conditions. Pupillography observes pupil responses to light, assessing deeper visual pathways in the brain. Videography studies how light affects headaches, with evidence suggesting that certain optical treatments can reduce light sensitivity. Wrist-watch sensors track light exposure in real-time, offering insights into how light influences mood and alertness.56789

Are You a Good Fit for This Trial?

This trial is for healthy individuals aged 18-80 who have had a normal eye exam in the past year. It's designed to help those with traumatic brain injury and associated light sensitivity or migraines by objectively measuring their response to light.

Inclusion Criteria

Healthy individuals with normal eye exam in the previous year

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Assessment

Objective measurement of facial features, pupil responses, retinal electrical responses, and autonomic nerve responses to light

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after assessment

2-4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Electrophysiology
  • Ocular Coherence Tomography (OCT)
  • Pupillography
  • Videography
  • Wrist-watch sensor device
Trial Overview The study tests new methods like videography, ocular coherence tomography (OCT), wrist-watch sensor devices, pupillography, and electrophysiology to diagnose and monitor treatment of light sensitivity and headaches in patients.
How Is the Trial Designed?
5Treatment groups
Active Control
Group I: TBI patients with photosensitivityActive Control5 Interventions
Group II: TBI Patients without photosensitivityActive Control5 Interventions
Group III: Migraine patients with photosensitivityActive Control5 Interventions
Group IV: Migraine patients without photosensitivityActive Control5 Interventions
Group V: Healthy Control subjectsActive Control5 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Randy Kardon

Lead Sponsor

Trials
4
Recruited
1,100+

Published Research Related to This Trial

The study identified specific pupillary light reflex parameters that differ significantly between individuals with and without photosensitivity, suggesting these could serve as objective biomarkers for photosensitivity.
In individuals with mild traumatic brain injury (mTBI), distinct differences in pupil response were observed, including larger baseline diameter and faster recovery times, indicating that pupillometry could help assess photosensitivity in this population.
Objective Pupillary Correlates of Photosensitivity in the Normal and Mild Traumatic Brain Injury Populations.Truong, JQ., Ciuffreda, KJ.[2017]
The 2017 EOG Standard from ISCEV updates the guidelines for the clinical electro-oculogram test, which measures the electrical potential changes in the outer retina and retinal pigment epithelium during light and dark adaptation.
The standard emphasizes the importance of the light peak:dark trough ratio (previously known as the Arden ratio) as the main clinical measure, aiming to enhance consistency and quality in EOG testing across different clinical centers.
ISCEV Standard for clinical electro-oculography (2017 update).Constable, PA., Bach, M., Frishman, LJ., et al.[2018]
Electroretinograms (ERG) and pattern-electroretinograms (PERG) can be recorded in pigs, but the amplitudes are generally small, indicating that these methods may not be sensitive enough to detect minor retinal damage.
High variability in ERG and PERG measurements suggests that only significant retinal damage, such as that caused by vitrectomy or erbium:YAG laser treatment, would likely result in noticeable changes in these readings.
Steady-state electroretinograms and pattern electroretinograms in pigs.Janknecht, P., Wesendahl, T., Feltgen, N., et al.[2019]

Citations

What can visual electrophysiology tell about possible visual ...The field-specific VEP had a sensitivity of 75% and a specificity of 87.5% [55]. This technique was further developed by Hébert-Lalonde et al. [56, 57] that ...
Developments in non-invasive visual electrophysiologyTwo main techniques are available: the electroretinogram (ERG), a mass potential originating in the retina, and the visual evoked potential (VEP).
Electrodiagnostic tests of the visual pathway and ...This article describes the main visual electrodiagnostic tests relevant to neuro-ophthalmology practice, including the visual evoked potential (VEP),
Use of Visual Electrophysiology to Monitor Retinal and ...Electrophysiologic changes reported with EON include a reduction in the difference of the maximum b-wave amplitude relative to the maximum a- ...
Visual electrophysiology and “the potential of the potentials”Electrophysiology permits direct, objective and quantitative assessment of function, both at the level of the visual cortex (visual evoked potentials, VEPs) and ...
The Electroretinogram and Electro-oculogram: Clinical ... - NCBIThe ERG is a test used worldwide to assess the status of the retina in eye diseases in human patients and in laboratory animals used as models of retinal ...
Characteristics of visual evoked potentials related to the ...In this study, we analysed visual evoked potentials (VEPs) in three different samples: i) 38 photosensitive patients (21 males, 17 females; mean age 10.0 ± 2.9 ...
Clinical electrophysiology of the optic nerve and retinal ...The electrophysiology of the optic nerve and RGCs has been well established through the Visual Evoked Potential (VEP) and Pattern ...
Visual ElectrophysiologyThe visual evoked potential (VEP) provides important diagnostic information regarding the functional integrity of the visual system. It measures the electrical ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security